180 related articles for article (PubMed ID: 15147331)
1. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
Grandi AM; Laurita E; Selva E; Piantanida E; Imperiale D; Giovanella L; Guasti L; Venco A
Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
[TBL] [Abstract][Full Text] [Related]
4. [Cardiac natriuretic peptides as markers of left ventricular dysfunction].
Omland T; Aakvaag A; Vik-Mo H
Tidsskr Nor Laegeforen; 1997 Mar; 117(7):943-8. PubMed ID: 9103004
[TBL] [Abstract][Full Text] [Related]
5. Prolonged stability of brain natriuretic peptide: importance for non-invasive assessment of cardiac function in clinical practice.
Buckley MG; Marcus NJ; Yacoub MH; Singer DR
Clin Sci (Lond); 1998 Sep; 95(3):235-9. PubMed ID: 9730841
[TBL] [Abstract][Full Text] [Related]
6. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H
Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.
Su X; Brower G; Janicki JS; Chen YF; Oparil S; Dell'Italia LJ
J Mol Cell Cardiol; 1999 Oct; 31(10):1927-36. PubMed ID: 10525429
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of natriuretic peptides and adrenomedullin in elderly hypertensive patients: relationships to 24 h blood pressure.
Kario K; Nishikimi T; Yoshihara F; Takishita S; Yamaoka R; Matsuo T; Matuso H; Mitsuhashi T; Shimada K; Kangawa K
J Hypertens; 1998 Sep; 16(9):1253-9. PubMed ID: 9746111
[TBL] [Abstract][Full Text] [Related]
9. [Factors that influence the serum of atrial natriuretic peptide and brain natriuretic peptide concentrations--is there a specific marker for senile patients?].
Sayama H; Nakamura Y; Saitou N; Doi Y; Matsukura S; Sakurai H; Kinoshita M
Nihon Ronen Igakkai Zasshi; 1998 Nov; 35(11):851-7. PubMed ID: 10064973
[TBL] [Abstract][Full Text] [Related]
10. Central obesity and hypertension: the role of plasma endothelin.
Parrinello G; Scaglione R; Pinto A; Corrao S; Cecala M; Di Silvestre G; Amato P; Licata A; Licata G
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1186-91. PubMed ID: 8972889
[TBL] [Abstract][Full Text] [Related]
11. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic correlates of atrial natriuretic peptide concentration in unselected patients with heart disease of different etiologies.
La Vecchia L; Fortunato A; Varotto L; Bonanno C; Paccanaro M; Ometto R; Vincenzi M
G Ital Cardiol; 1998 Dec; 28(12):1363-71. PubMed ID: 9887389
[TBL] [Abstract][Full Text] [Related]
13. Pulsatile secretion of atrial natriuretic peptide and brain natriuretic peptide in healthy humans.
Pedersen EB; Pedersen HB; Jensen KT
Clin Sci (Lond); 1999 Aug; 97(2):201-6. PubMed ID: 10409475
[TBL] [Abstract][Full Text] [Related]
14. Natriuretic peptides in assessment of left-ventricular dysfunction.
Mair J; Friedl W; Thomas S; Puschendorf B
Scand J Clin Lab Invest Suppl; 1999; 230():132-42. PubMed ID: 10389212
[TBL] [Abstract][Full Text] [Related]
15. [Atrial natriuretic peptide (ANP) in essential hypertension: a humoral marker for salt sensitivity and hypertensive heart disease at a clinically asymptomatic stage?].
Stimpel M; Kaufmann W; Wambach G
Z Kardiol; 1988; 77 Suppl 2():92-8. PubMed ID: 2970180
[TBL] [Abstract][Full Text] [Related]
16. Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension.
Cheung BM; Brown MJ
J Hypertens; 1994 Apr; 12(4):449-54. PubMed ID: 8064169
[TBL] [Abstract][Full Text] [Related]
17. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension.
Yasumoto K; Takata M; Ueno H; Tomita S; Tomoda F; Inoue H
Am J Hypertens; 1999 Sep; 12(9 Pt 1):921-4. PubMed ID: 10509551
[TBL] [Abstract][Full Text] [Related]
18. Exaggerated atrial natriuretic peptide release during acute exercise in essential hypertension.
Sudhir K; Woods RL; Jennings GL; Nelson LA; Laufer E; Korner PI
J Hum Hypertens; 1988 Mar; 1(4):299-304. PubMed ID: 2975706
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide and 24 h blood pressure.
Guasti L; Grimoldi P; Ceriani L; Gaudio G; Bertolini A; Giovanella L; Grandi AM; Roncari G; Venco A
Blood Press Monit; 1997 Apr; 2(2):89-92. PubMed ID: 10234098
[TBL] [Abstract][Full Text] [Related]
20. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
